Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model

This publication has 18 references indexed in Scilit:

• Met, the Hepatocyte Growth Factor Receptor, Localizes to the Nucleus in Cells at Low Density
  Cancer Research, 2006
• Quantitative In situ Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome
  Cancer Research, 2006
• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
  JNCI Journal of the National Cancer Institute, 2005
• Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
  Proceedings of the National Academy of Sciences, 2005
• X-Tile
  Clinical Cancer Research, 2004
• Tissue microarray‐based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors
  Cancer, 2003
• HGF/SF‐met signaling in the control of branching morphogenesis and invasion
  Journal of Cellular Biochemistry, 2003
• Automated subcellular localization and quantification of protein expression in tissue microarrays
  Nature Medicine, 2002
• Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints
  The American Journal of Pathology, 2001
• Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland.
  The Journal of cell biology, 1995